Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Priam Villalonga"'
Publikováno v:
Cells, Vol 11, Iss 23, p 3716 (2022)
Enhanced invasiveness is one of the defining biological traits of glioblastoma cells, which exhibit an infiltrative nature that severely hinders surgical resection. Among the molecular lesions responsible for GBM aggressiveness, aberrant receptor tyr
Externí odkaz:
https://doaj.org/article/4163bbf3171f43e293e9a7159c6b61a3
Autor:
Lamiae Belayachi, Clara Aceves-Luquero, Nawel Merghoub, Youssef Bakri, Silvia Fernández de Mattos, Saaïd Amzazi, Priam Villalonga
Publikováno v:
BMC Complementary Medicine and Therapies, Vol 22, Iss 1, Pp 1-1 (2022)
Externí odkaz:
https://doaj.org/article/a6ace252b28247a3a177f5f5a5570613
Autor:
Marta González-Bártulos, Clara Aceves-Luquero, Jamal Qualai, Olaf Cussó, M Angeles Martínez, Silvia Fernández de Mattos, Javier A Menéndez, Priam Villalonga, Miquel Costas, Xavi Ribas, Anna Massaguer
Publikováno v:
PLoS ONE, Vol 10, Iss 9, p e0137800 (2015)
Differential redox homeostasis in normal and malignant cells suggests that pro-oxidant-induced upregulation of cellular reactive oxygen species (ROS) should selectively target cancer cells without compromising the viability of untransformed cells. Co
Externí odkaz:
https://doaj.org/article/8b256cdd40af4e208f7bf16c35468953
Autor:
Guillem Ramis, Elena Thomàs-Moyà, Silvia Fernández de Mattos, José Rodríguez, Priam Villalonga
Publikováno v:
PLoS ONE, Vol 7, Iss 6, p e38770 (2012)
Enforced EGFR activation upon gene amplification and/or mutation is a common hallmark of malignant glioma. Small molecule EGFR tyrosine kinase inhibitors, such as erlotinib (Tarceva), have shown some activity in a subset of glioma patients in recent
Externí odkaz:
https://doaj.org/article/d06f26067a09453291cec28ad7546bc0
Autor:
Joan Bestard Escalas, Santiago Garfias Arjona, Marta Brell Doval, Priam Villalonga, Javier Pierola Lopetegui, Albert Maimó Barceló, Ruth Villalonga-Planells, Olga Delgado Sánchez, Javier Ángel Ibáñez Domínguez, Mónica Lara Almunia
Publikováno v:
Acta Neurochirurgica. 161:1733-1741
5-Aminolevulinic acid (5-ALA) has become an important assistant in glioblastoma (GB) surgery. Unfortunately, its price affects its widespread use. The aim of this study was to compare commercial 5-ALA with the pharmacy-compounded solution. Using firs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb543fc205c4a5042fd73f7d6a443d80
https://doi.org/10.1007/s00701-019-03930-4
https://doi.org/10.1007/s00701-019-03930-4
Publikováno v:
Encyclopedia of Biological Chemistry III ISBN: 9780128220405
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::baa3da8bd859de170e24ff70b104c28b
https://doi.org/10.1016/b978-0-12-819460-7.00195-x
https://doi.org/10.1016/b978-0-12-819460-7.00195-x
Autor:
Borja Sesé, Sandra Íñiguez-Muñoz, Miquel Ensenyat-Mendez, Pere Llinàs-Arias, Guillem Ramis, Javier I. J. Orozco, Silvia Fernández de Mattos, Priam Villalonga, Diego M. Marzese
Publikováno v:
Cancers; Volume 14; Issue 9; Pages: 2070
Glioma stem cells (GSCs) are a subset of cells with self-renewal and tumor-initiating capacities that are thought to participate in drug resistance and immune evasion mechanisms in glioblastoma (GBM). Given GBM heterogeneity, we hypothesized that GSC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6cbfd7404960346a60c317de8cb5505
https://doi.org/10.3390/cancers14092070
https://doi.org/10.3390/cancers14092070
Autor:
Priam Villalonga, Silvia Fernández de Mattos, José M. Llinares, Cristina Galiana-Roselló, Álvaro Martínez-Camarena, Enrique García-España, María Eugenia González-Rosende, Concepción Soriano, Jorge González, Ruth Villalonga, Clara Aceves-Luquero
Publikováno v:
Journal of medicinal chemistry. 63(3)
In vitro viability assays against a representative panel of human cancer cell lines revealed that polyamines L1a and L5a displayed remarkable activity with IC50 values in the micromolar range. Preliminary research indicated that both compounds promot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3374dac854c32a498535aa5896df3c12
https://pubmed.ncbi.nlm.nih.gov/31935092
https://pubmed.ncbi.nlm.nih.gov/31935092
Autor:
Margalida Serra-Sitjar, Marta Brell, Silvia Fernández de Mattos, Guillem Ramis, Ruth Villalonga-Planells, Priam Villalonga
Publikováno v:
Cellular oncology (Dordrecht). 42(4)
Although EGFR activation is a hallmark of glioblastoma (GBM), anti-EGFR therapy has so far not yielded the desired effects. Targeting PI3K/Akt has been proposed as a strategy to increase the cellular sensitivity to EGFR inhibitors. Here we evaluated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f05fd8fc316abf0754b3167efc89dfe
https://pubmed.ncbi.nlm.nih.gov/30980364
https://pubmed.ncbi.nlm.nih.gov/30980364
Autor:
Clara Aceves-Luquero, Lamiae Belayachi, Silvia Fernández de Mattos, Nawel Merghoub, Priam Villalonga, Youssef Bakri, Saaïd Amzazi
Publikováno v:
African Journal of Traditional, Complementary and Alternative Medicines; Vol 14, No 2 (2017); 356-373
African Journal of Traditional, Complementary, and Alternative Medicines
African Journal of Traditional, Complementary, and Alternative Medicines
Background: Ormenis eriolepis Coss (Asteraceae) is an endemic Moroccan subspecies, traditionally named “Hellala” or “Fergoga”. It’s usually used for its hypoglycemic effect as well as for the treatment of stomacal pain. As far as we know, t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d10ec253c343c152563ded0e0b0c6120
https://www.ajol.info/index.php/ajtcam/article/view/152089
https://www.ajol.info/index.php/ajtcam/article/view/152089